4//SEC Filing
MEDNAX, INC. 4
Accession 0001209191-16-125669
$MDCIK 0000893949operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:37 PM ET
Size
6.8 KB
Accession
0001209191-16-125669
Insider Transaction Report
Form 4
Clark David A.
COO / Pediatrix Division
Transactions
- Sale
Common Stock
2016-06-01$67.78/sh−11,470$777,465→ 20,025 total - Award
Common Stock
2016-06-01+9,928→ 31,495 total
Footnotes (3)
- [F1]Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2017, June 1, 2018 and June 1, 2019.
- [F2]Sales made pursuant to Reporting Person's 105b-1 trading plan.
- [F3]Sales of shares were made in thirty-six separate transactions with prices ranging from $67.53 to $67.95 for a weighted average sales price of $67.7825.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000893949
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:37 PM ET
- Size
- 6.8 KB